Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
European CHMP Adopts Positive Opinion for Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

Epclusa is Gilead’s Third Sofosbuvir-Based Treatment to Receive a CHMP Positive Opinion for the Treatment of Chronic HCV Infection.

Published
27 May 2016
From
Gilled press relase
WHA69: Leave no one behind, World Hepatitis Alliance

Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week).

Published
25 May 2016
From
PLoS Blogs (blog)
Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England

Targeting new hepatitis C virus (HCV) direct-acting antivirals (DAAs) at patients with cirrhosis will substantially reduce short-term incidence of end-stage liver disease (ESLD) and liver cancer (HCC) in

Published
25 May 2016
By
Michael Carter
Primrose Healthcare Launches an Innovative Alcohol App to Help Hepatitis C Patients Overcome Alcohol Addiction

Leveraging mobile technology and powered by Here and Now Systems, the alcohol app provides personalized education and resources through goal setting, alerts, coaching, and ongoing feedback to better engage and support hepatitis C patients on their journey toward alcohol addiction recovery.

Published
24 May 2016
From
Business Wire (press release)
Next-generation HCV treatments should benefit challenging patient groups

Despite treatment success rates of 95 percent and better, hepatitis C (HCV) therapy can still improve. Finding a universal cure is the goal, according to Michael Fried, MD, professor of medicine and director of the UNC Liver Center at the University of North Carolina, Chapel Hill.

Published
23 May 2016
From
Digestive Disease Week blog
Could hepatitis C treatments help prevent virus transmission?

In a study looking specifically at HCV infection rates in HIV-positive gay men, the researchers found the proportion of HIV positive gay men with HCV increased slightly from 2004 to 2011, and that current treatment rates were unlikely to reduce HCV transmission over time.

Published
19 May 2016
From
Eurekalert Inf Dis
The Hepatitis C Trust is considering seeking a judicial review of NHS England’s decision to ration access to hepatitis C treatment

The Hepatitis C Trust wrote to NHS England to ask it to reconsider its decision to limit the number of people with hepatitis C who are allowed access to new NICE approved drugs that cure the disease. On Monday 16th May, 2016 NHS England replied with a response that The Hepatitis C Trust did not find satisfactory. With great regret it now has to consider seeking a judicial review of the decision.

Published
18 May 2016
From
Hepatitis C Trust
Outside the biomedical box of hepatitis C research

Interview with Magdalena Harris, Lecturer at the London School of Hygiene and Tropical Medicine, on how she came to work with viral hepatitis, how the field has been changing, and what new research is called for.

Published
17 May 2016
From
BioMed Central blogs
Consultation for action plans on HIV and viral hepatitis

The joint Tuberculosis, HIV/AIDS and Hepatitis Programme of the WHO Regional Office for Europe is developing two action plans to address the HIV and viral hepatitis epidemics in the WHO European Region.

Published
17 May 2016
From
WHO Europe
Does having HIV affect response to hepatitis C treatment?

A study from the US Veterans Health Administration found that HIV-positive people responded as well as those without HIV to direct-acting antiviral (DAA) therapy for hepatitis C,

Published
16 May 2016
By
Liz Highleyman
← First12345...154Next →

Filter by country